CB 3717 Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

CB 3717, a potent inhibitor of thymidylate synthase, is toxic for cell lines with altered dihydrofolate reductase; and homofolate, a de novo purine inhibitor requiring dihydrofolate reductase for activation, is effective in reductase-amplified lines.

Hazard

A poison.

CB 3717 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CB 3717 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	32161	58
Hu Bei Jiutian Bio-medical Technology CO.,Ltd	027-88013699 17354350817	Ryan@jiutian-bio.com	China	6001	58
TargetMol Chemicals Inc.	+8613564774135	zijue.cai@tsbiochem.com	United States	19885	58
SPIRO PHARMA		eric_feng1954@126.com	China	9248	55
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	19704	58

---

• CB 3717
• 10-Propargyl-5,8-dideazafolate
• 10-Propargyl-5,8-dideazafolic acid
• N-[4-[[(2-Amino-1,4-dihydro-4-oxoquinazolin-6-yl)methyl]-2-propynylamino]benzoyl]-L-glutamic acid
• N-[p-[Propargyl(2-amino-4-hydroxyquinazolin-6-ylmethyl)amino]benzoyl]-L-glutamic acid
• PDDF
• LTKHPMDRMUCUEB-IBGZPJMESA-N
• L-Glutamic acid, N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propyn-1-ylamino]benzoyl]-
• 8-dideazafolic acid
• N(sup 10)-Propargyl-5
• N(sup 10)-Propargyl-5,8-dideazafolic acid
• N¹⁰)-PROPARGYL-5,8-DIDEAZAFOLIC ACID
• 76849-19-9